neo-gambogic acid has been researched along with Cancer of Lung in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 7 (87.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Liu, C; Niu, H; Shen, D; Wang, Y | 1 |
Fu, W; Lao, Y; Li, X; Meng, X; Qian, J; Tan, H; Tu, S; Xu, H; Xu, L; Xu, N; Zhang, L; Zhou, Q | 1 |
Cheng, H; Hu, RF; Li, QL; Su, JJ; Wang, YL | 1 |
Huang, T; Jia, J; Wang, X; Xu, L; Zhang, H; Zhu, X | 1 |
Bin, L; Cheng, P; Dong, C; Fenggen, Y; Guanghui, W; Hui, C; Jingjing, S; Mei, W; Meiling, S; Qinglin, L; Xiaoshan, W; Yawen, H; Zhiwu, C | 1 |
Cheng, H; Fang, N; Li, Q; Peng, D; Su, J; Wang, M; Wang, X; Xia, L; Xu, Q; Yang, L; Zhou, A; Zhu, G | 1 |
Cheng, H; Li, Q; Wang, M; Yang, L | 1 |
Gao, J; Han, QB; Ma, L; Wen, ZS; Yu, XJ; Zhou, GB | 1 |
8 other study(ies) available for neo-gambogic acid and Cancer of Lung
Article | Year |
---|---|
Gambogenic acid exerts anticancer effects in cisplatin‑resistant non‑small cell lung cancer cells.
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Resistance, Neoplasm; G1 Phase; Humans; Lung Neoplasms; Neoplasm Proteins; Xanthenes | 2020 |
Gambogenic acid inhibits fibroblast growth factor receptor signaling pathway in erlotinib-resistant non-small-cell lung cancer and suppresses patient-derived xenograft growth.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Phosphorylation; Protein Kinase Inhibitors; Receptors, Fibroblast Growth Factor; Signal Transduction; Tumor Burden; Xanthenes; Xenograft Model Antitumor Assays | 2018 |
[Mechanism of gambogenic acid in resisting angiogenesis of lung cancer in vitro].
Topics: A549 Cells; Apoptosis; Coculture Techniques; Human Umbilical Vein Endothelial Cells; Humans; Lung Neoplasms; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Transfection; Xanthenes | 2018 |
Gambogenic acid inhibits the proliferation of small‑cell lung cancer cells by arresting the cell cycle and inducing apoptosis.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Garcinia; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Small Cell Lung Carcinoma; Xanthenes; Xenograft Model Antitumor Assays | 2019 |
Gambogenic acid kills lung cancer cells through aberrant autophagy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Gene Knockdown Techniques; HeLa Cells; Humans; Lung Neoplasms; Lysosomes; Male; Membrane Proteins; Mice; Phagosomes; Terpenes; Xanthenes; Xanthones; Xenograft Model Antitumor Assays | 2014 |
Gambogenic acid inhibits proliferation of A549 cells through apoptosis-inducing and cell cycle arresting.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclooxygenase 2; Dose-Response Relationship, Drug; Down-Regulation; Female; Garcinia; Gene Expression Regulation; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Phytotherapy; Plant Extracts; Resins, Plant; RNA, Messenger; Terpenes; Xanthenes; Xanthones; Xenograft Model Antitumor Assays | 2010 |
[Gambogenic acid inhibits proliferation of A549 cells through apoptosis-inducing].
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Electron, Transmission; Terpenes; Vascular Endothelial Growth Factor A; Xanthenes; Xanthones; Xenograft Model Antitumor Assays | 2011 |
Gambogenic acid induces G1 arrest via GSK3β-dependent cyclin D1 degradation and triggers autophagy in lung cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Autophagy; Cell Line, Tumor; Cyclin D1; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p27; Enzyme Activation; G1 Phase Cell Cycle Checkpoints; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Lung Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; Terpenes; TOR Serine-Threonine Kinases; Xanthenes; Xanthones | 2012 |